![]() ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ![]() Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | ![]() Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 1981 | Founding Date 1999 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ | Locations Marseille, FR HQ Rockville, US | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 277161% increase | Employees 181 | Employees 180 |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 148.6 m | Valuation ($) 280.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) €2.8m (FY, 2025) | Revenue (est.) €65.4m (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods €266k (FY, 2025) | Cost of goods €302k (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit €8.7m (FY, 2025) | Gross profit €70.8m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income (€49.2m) (FY, 2025) | Net income (€86m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 94.1m | Total funding raised N/A |

Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company